Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review

BRCA1 and BRCA2 germline deleterious variants are associated with a high risk of hereditary breast and ovarian cancer. The presence of pathogenic variants in both genes in the same individual (double heterozygosity) is rare and often associated with distinct clinical characteristics. We report a rare case of double heterozygosity involving a novel combination of pathogenic variants. A 40-year-old woman was diagnosed with stage IIIA invasive ductal carcinoma of the right breast. Histopathology revealed a grade 2, ER-positive (100%), PR-positive (70%), HER2-negative (FISH), high-proliferation Luminal B tumor. She received neoadjuvant dose-dense AC chemotherapy. Germline testing via next-generation sequencing identified two pathogenic variants: NM_007294.4 (BRCA1) :c.2105del (p.Lys701_Leu702ins*) in exon 11 and NM_000059.4 (BRCA2): c.1763_1766del (p.Asn588Serfs*25) in exon 10, both heterozygous. The patient reported a strong maternal family history of breast cancer. A systematic review of the literature and databases (PubMed, ClinVar, BRCA Exchange) did not reveal any previous clinical reports of this specific variant combination. Cases of double heterozygosity remain rare (<0.5% of BRCA carriers), and clinical data on variant-specific co-occurrence is limited. This case represents the first known report of a patient carrying both NM_007294.4 ( BRCA1 ): c.2105del (p.Lys701_Leu702ins*) and NM_000059.4 ( BRCA2 ): c.1763_1766del (p.Asn588Serfs*25) pathogenic variants. The findings contribute valuable information to the spectrum of hereditary breast cancer and underscore the importance of comprehensive genetic testing, especially in patients with strong family histories.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-13
DOI
https://doi.org/10.3389/fonc.2026.1913265
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review

Katherine Aguirre-Guataqui, Mario A. Isaza-Ruget, Juan Javier López Rivera, Paula Rueda‐Gaitán et al.
Frontiers in Oncology
BRCA gene mutations in cancer
article

Multilocus inherited neoplasia alleles syndrome in a patient with luminal B breast cancer: a case report and literature review

Katherine Aguirre-Guataqui, Mario A. Isaza-Ruget, Juan Javier López Rivera, Paula Rueda‐Gaitán, Natalia Hernández-Bocanegra, Taryn A Castro-Cuesta, Julian Lamilla, Jorge Luis Rodríguez-Sarmiento
article en

Abstract

BRCA1 and BRCA2 germline deleterious variants are associated with a high risk of hereditary breast and ovarian cancer. The presence of pathogenic variants in both genes in the same individual (double heterozygosity) is rare and often associated with distinct clinical characteristics. We report a rare case of double heterozygosity involving a novel combination of pathogenic variants. A 40-year-old woman was diagnosed with stage IIIA invasive ductal carcinoma of the right breast. Histopathology revealed a grade 2, ER-positive (100%), PR-positive (70%), HER2-negative (FISH), high-proliferation Luminal B tumor. She received neoadjuvant dose-dense AC chemotherapy. Germline testing via next-generation sequencing identified two pathogenic variants: NM_007294.4 (BRCA1) :c.2105del (p.Lys701_Leu702ins*) in exon 11 and NM_000059.4 (BRCA2): c.1763_1766del (p.Asn588Serfs*25) in exon 10, both heterozygous. The patient reported a strong maternal family history of breast cancer. A systematic review of the literature and databases (PubMed, ClinVar, BRCA Exchange) did not reveal any previous clinical reports of this specific variant combination. Cases of double heterozygosity remain rare (<0.5% of BRCA carriers), and clinical data on variant-specific co-occurrence is limited. This case represents the first known report of a patient carrying both NM_007294.4 ( BRCA1 ): c.2105del (p.Lys701_Leu702ins*) and NM_000059.4 ( BRCA2 ): c.1763_1766del (p.Asn588Serfs*25) pathogenic variants. The findings contribute valuable information to the spectrum of hereditary breast cancer and underscore the importance of comprehensive genetic testing, especially in patients with strong family histories.

Frontiers in OncologyVol. 16
Fundación Universitaria Sanitas (CO)
Good health and well-being
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon